ClinicalTrials.gg
CompletedNCT06301139Updated Mar 8, 2024

Goat Milk Infant Formula Comfort Study

An interventional study of Goat milk-based infant formula and Cow's milk-based infant formula with probiotic drops in Gastrointestinal Diseases and Cow's Milk Intolerance, sponsored by Ausnutria Hyproca B.V.. Completed at 1 site in Spain. Open to participants aged 6 Weeks to 3 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-08.

Sponsored by Ausnutria Hyproca B.V. · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 years 9 months after the study started (first participant enrolled May 2019, registered Feb 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
6 Weeks to 3 Months
Sex
All
01

Study summary

In this study, the investigators aim to assess that infants with mild symptoms have significantly less (severe) symptoms after 14 days goat milk-based formula use compared to infants using cow's milk-based formula supplemented with probiotic drops.

Read the detailed description

Anecdotal evidence shows that the use of goat milk-based infant formula decreases discomfort of infants with cow's milk related symptoms. In this randomized controlled pilot study, the effect on comfort during usage of goat-milk based infant formula is studied. Twenty formula fed infants (aged between 6 weeks and 3 months) who experience mild discomfort will receive goat milk-based infant formula (GMF) or cow's mik based infant formula supplemented with probiotics lactobacillus reuteri drops (CMFp). The infants will be assessed by a local paediatricians using the Cow's Milk-related Symptom Score (CoMiSS). This is a fast, non-invasive and easy-to-use and validated questionnaire to assess infant's reaction to proteins found in cow's milk. The higher the score, the more sensitive the child is to cow's milk proteins, the maximum score is 33 points. Infants with a CoMiSS Score between 6 and 12 will be enrolled in this study. It is expected that infants will have a better response to GMF, which will result in a decrease of the CoMiSS Score after a 2 weeks intervention.

02

Conditions studied

  • Gastrointestinal Diseases
  • Cow's Milk Intolerance
03

In context

Gastrointestinal Diseases

548 studies on the registry are indexed under Gastrointestinal Diseases; 101 are open to participants now.

This study's enrollment of 18 is below the median of 80 across 388 interventional studies indexed under Gastrointestinal Diseases.

Browse Gastrointestinal Diseases studies →

Lead sponsor

Ausnutria Hyproca B.V. is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Weeks to 3 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy full-term infant with birth weight ≥2,500 to ≤4,500 g
  • Infant aged between 4 weeks and 3 months at enrolment
  • CoMiSS value at baseline between 6 and 12
  • Infant is exclusively bottle fed with cow's milk based infant formula at baseline

Exclusion criteria

Exclusion Criteria:

  • Breastfed infants
  • Congenital illness or malformation that may affect infant feeding or normal growth
  • Gastrointestinal disorders
  • Confirmed cow or goat milk protein allergy or lactose intolerance
  • Supplemental feeding
  • Readmission to hospital for longer than 3 days for another reason than hyperbilirubinemia prior to enrolment
  • Infant participating in another clinical study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
18 participants (actual)

Study arms

  • Experimental
    Goat milk-based formula

    goat milk-based infant formula (GMF)

    Dietary Supplement: Goat milk-based infant formula

  • Placebo comparator
    Cow's milk-based formula

    cow's milk-based infant formula supplemented with probiotics (CMFp)

    Dietary Supplement: Cow's milk-based infant formula with probiotic drops

Interventions

  • Dietary supplementGoat milk-based infant formula

    Infant formula based on goat milk for 4 weeks at volume depending on the infant

  • Dietary supplementCow's milk-based infant formula with probiotic drops

    Infant formula based on cow's milk with probiotic Lactobacillus reuteri drops for 4 weeks at volume depending on the infant

06

What researchers measure

Primary outcomes

  1. Cow's Milk-related Symptoms

    Difference in Cow's Milk related Symptom Score (CoMiSS: score ranges from 0 to 33 with higher scores indicating more symptoms) at baseline and after 14 days of intervention.

    Time frame: 0-2 weeks

Secondary outcomes

  1. Cow's Milk-related Symptoms

    Difference in Cow's Milk-related Symptoms Score (CoMiSS: score ranges from 0 to 33 with higher scores indicating more symptoms) at baseline and after 28 days of intervention.

    Time frame: 0-4 weeks

  2. Parental stress

    Difference in parental stress measured by Parental Stress Index-Short Form (PSI-SF: score ranges from 15% to 100% with higher scores indicating more stress) at baseline, after 5 days, after 9 days and after 28 days of intervention.

    Time frame: 0-4 weeks

  3. Parental quality of life

    Difference in parental quality of life measured by World Health Organization Quality Of Life questionnaire - short version (WHOQOL-BREF: score ranges from 0 to 100 with higher scores indicating better quality of life ) at baseline, after 5 days, after 9 days and after 28 days of intervention.

    Time frame: 0-4 weeks

  4. Weight

    Difference in weight (grams) at baseline, after 14 days and after 28 days of intervention.

    Time frame: 0-4 weeks

  5. Length

    Difference in length (cm) at baseline, after 14 days and after 28 days of intervention.

    Time frame: 0-4 weeks

  6. Weight-for-age

    Difference in weight-for-age z-scores calculated using the World Health Organization Child Growth Standards at baseline, after 14 days and after 28 days of intervention.

    Time frame: 0-4 weeks

  7. Length-for-age

    Difference in length-for-age z-scores calculated using the World Health Organization Child Growth Standards at baseline, after 14 days and after 28 days of intervention.

    Time frame: 0-4 weeks

  8. Weight-for-length

    Difference in weight-for-length z-scores calculated using the World Health Organization Child Growth Standards at baseline, after 14 days and after 28 days of intervention.

    Time frame: 0-4 weeks

07

Study locations

1 site
  • HM hospitales
    Madrid, 28015, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06301139
Lead sponsor
Ausnutria Hyproca B.V.
Collaborators
HM hospitales
Responsible party
Sponsor
First posted
Mar 8, 2024
Start date
May 1, 2019
Primary completion
Apr 1, 2021
Completion
Feb 1, 2024
Last update
Mar 8, 2024

Study contacts

Alejandro López-Escobar, Dr.
principal investigator · Hospital Universitario General de Villalba

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion